Quantcast

Latest Trisomy Stories

2011-07-05 12:14:03

Ovarian stimulation undertaken by women of advanced maternal age (over 35 years) receiving fertility treatment may be disrupting the normal pattern of meiosis "“ a critical process of chromosome duplication followed by two specialized cell divisions in the production of oocytes and sperm "“ and leading to abnormalities of chromosome copy numbers (aneuploidy) that result in IVF failure, pregnancy loss or, more rarely, the birth of affected children with conditions such as Down's...

2011-07-04 12:49:36

ESHRE study may answer the question in older women Ovarian stimulation undertaken by women of advanced maternal age (over 35 years) receiving fertility treatment may be disrupting the normal pattern of meiosis "“ a critical process of chromosome duplication followed by two specialised cell divisions in the production of oocytes and sperm "“ and leading to abnormalities of chromosome copy numbers (aneuploidy) that result in IVF failure, pregnancy loss or, more rarely, the birth of...

2011-03-08 15:30:00

SAN DIEGO, March 8, 2011 /PRNewswire/ -- Sequenom, Inc. (Nasdaq: SQNM) today reported its financial results for the fourth quarter and the year ended December 31, 2010. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO) Fourth Quarter Results Total revenue for the fourth quarter of 2010 grew 28% to $13.8 million, compared with $10.8 million for the fourth quarter of 2009. The increase in revenue compared to the same period last year was primarily due to higher system and...

2011-02-10 14:04:32

According to new study published in the American Journal of Obstetrics & Gynecology In 1980 in the United States, approximately 4.5% of all pregnant women were of advanced maternal age. By 2007 that figure had increased to 14%. Women over 35 are at increased risk of giving birth to babies with trisomy 21. In a study published online today in the American Journal of Obstetrics & Gynecology (AJOG), researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing...

9b425778ce457868d7a7b81fbf8563d8
2011-01-12 12:50:00

Research published on Tuesday states that DNA in a pregnant woman's blood can reliably show whether her fetus has Down's syndrome, which can reduce the need for invasive testing procedures like amniocentesis. Down's syndrome, a major developmental disorder also known as trisomy 21, occurs in around one in every 800 live births. Pre-natal diagnosis mainly entails sampling fluid from the amniotic sac enveloping the fetus.  Another technique is called chorionic villus sampling, and it...

2010-07-29 17:13:22

A genetics research team based at The Children's Hospital of Philadelphia continues to discover recurrent translocations"”places in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal chromosome composition and disabilities resulting from disrupted, extra or missing copies of genes. While rare, such diseases...

2010-07-29 11:00:00

PHILADELPHIA, July 29 /PRNewswire-USNewswire/ --A genetics research team based at The Children's Hospital of Philadelphia continues to discover recurrent translocations--places in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA. Most such people appear healthy, but may have a child with abnormal chromosome composition and disabilities resulting from disrupted, extra or missing...

2010-07-21 13:49:00

SEATTLE, July 21 /PRNewswire/ -- A Seattle-area mother and her four-month-old daughter represent a tiny number of births nationwide - perhaps among the first three- using a technology that could be the next major advancement in reducing multiple miscarriages. Sheila Gruber, 34, of Duval, had suffered two consecutive miscarriages prior to undergoing a form of in vitro fertilization (IVF) and embryonic analysis that allows geneticists to examine about one-fourth of the entire human genome...

2010-06-30 03:49:00

LONDON, June 30 /PRNewswire/ -- Frost & Sullivan is pleased to announce that it has awarded its prestigious 2010 Scandinavia New Product Innovation Award to FCMB ApS ("FCMB") for its breakthrough work in non-invasive prenatal testing. FCMB is developing a suite of non-invasive prenatal diagnostics based on isolating fetal cells from maternal blood samples. FCMB's diagnostics have the potential to provide results that are as accurate as more invasive procedures, such as amniocentesis...

2010-01-19 13:09:00

Dedicated to Saving Children's Lives in CHASE COMMUNITY GIVING CHALLENGE MIDDLETOWN, Ohio and DALE CITY, Va., Jan. 19 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy together with Trisomy 18 Foundation are among 100 charities that earned a $25,000 grant during Round 1 of the Chase Community Giving Challenge on Facebook. Now in Round 2, Chase Bank has given them the opportunity to compete for an additional $1 Million prize and five $100,000 prizes, to be decided by public...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related